China approves phase 2 trial of recombinant protein COVID-19 vaccine, ReCOV

Jiangsu Recbio Technology Co., Ltd. has recently received the clinical trial approval for its recombinant protein COVID-...

May 5, 2022 | Thursday | News
China holds significant dominance in Asia breast cancer screening market: Report

According to the ResearchAndMarkets.com recent report, Asia Breast Cancer Screening Market is expected to reach $16...

May 4, 2022 | Wednesday | News
Hong Kong links gut microbial enzymes with colon inflammation

A Hong Kong Baptist University (HKBU) collaborative research study has revealed that certain gut microbial enzymes media...

May 4, 2022 | Wednesday | News
NiKang Therapeutics, Hansoh Pharma ink $200M worth deal for cancer treatment in Greater China

NiKang Therapeutics , a clinical stage biotech company focused on developing innovative small molecule oncology medicine...

May 4, 2022 | Wednesday | News
China Mobile Hong Kong launches online medical app "Dr. HK"

China Mobile Hong Kong (CMHK) has announced the launch of "Dr. HK", an online doctor consultation and medical app p...

May 4, 2022 | Wednesday | News
Zhifei Lvzhu Biopharmaceutical to commercialise whooping cough vaccine in China

Intravacc B.V., located at Utrecht Science Park Bilthoven in the Netherlands, has announced the signing o...

May 3, 2022 | Tuesday | News
China-based Biocytogen enters into antibody agreement with Merck

China's Biocytogen Pharmaceuticals has entered into an evaluation and option agreement with Merck to grant them a sole l...

May 2, 2022 | Monday | News
China-based I-Mab appoints new COO and CMO

China's I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization...

April 29, 2022 | Friday | News
Visirna brings RNAi therapeutics for cardiovascular & metabolic diseases in Greater China

US-based Arrowhead Pharmaceuticals, Inc. has formed a joint venture, Visirna Therapeutics, with Vivo Capital t...

April 29, 2022 | Friday | News
Hong Kong holds first clinical trial of novel oral treatment for COVID-19

The Chinese University of Hong Kong (CUHK)’s Clinical Trial Centre has announced its collaboration with CUHK Medic...

April 28, 2022 | Thursday | News
China's Antengene looks to start phase I trial in Australia

China's Antengene Corporation, a leading innovative, commercial-stage global biopharmaceutical company dedicated to disc...

April 27, 2022 | Wednesday | News
Lupin partners with Yabao Pharma for paediatric formulations in China

Indian firm Lupin has entered into a strategic partnership with Yabao Pharmaceutical Co, to meet the growing demand for ...

April 27, 2022 | Wednesday | News
China releases first international COVID-19 testing standard

According to the State Administration for Market Regulation in China, the International Organization for Standardization...

April 26, 2022 | Tuesday | News
Startups accelerate cell therapy development for solid tumours in China

China-based startups Suzhou Porton Advanced Solutions and Guizhou Sinorda Biomedicine have announced a long-term strateg...

April 25, 2022 | Monday | News
Wallaby acquires German neurovascular leader Phenox to accelerate global expansion

Wallaby Medical, a global innovative medical technology company focused on developing and commercializing neurovascular ...

April 22, 2022 | Friday | News
Lynk Pharmaceuticals gets clinical approval in China for Class I New Drug LNK01004

Lynk Pharmaceuticals, an innovative clinical stage company, has announced that its Class I innovative drug LNK01004, has...

April 22, 2022 | Friday | News
ATUM accelerates entry of bioengineering solutions into Chinese pharmaceutical market

US-based ATUM has announced a distribution partnership with Trio Biotech to market and promote ATUM’s unique Leap-...

April 21, 2022 | Thursday | News
China's ImmVira partners with Roche for cancer therapy

China-based startup ImmVira has reached a cooperation agreement with Roche to establish clinical research partnership re...

April 20, 2022 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls